Celyad Oncology to Announce First Half 2022 Financial

MONT-SAINT-GUIBERT, Belgium, July 28, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company...

Related Keywords

Mont Saint Guibert ,Waals Gewest ,Belgium ,New York ,United States ,Walloon Region ,Lincoln Park ,Ukraine ,Sara Zelkovic ,Lincoln Park Capital Fund ,Exchange Commission ,Communications Investor Relations ,Celyad Oncology ,Private Securities Litigation Reform Act ,Annual Report ,Media Contacts ,Nasdaq Cyad ,Elyad Oncology Sa ,